JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Rallybio (RLYB – Research Report) today and set a price target of $7.00.

JMP Securities lowered the firm’s price target on Esperion (ESPR) to $4 from $7 and keeps an Outperform rating on the shares. JMP updated its ...

The dental insurance industry plays a critical role in the broader healthcare ecosystem. Over the past decade, it has expanded access to essential dental services while simultaneously addressing the ...